Anogenital cancers testing in Segrate

Find health labs to test for Anogenital cancers in Segrate and compare all offers by prices and services.

Tests that cover Anogenital cancers

HPV Test
Pap Smear by Synlab

Via Antonio Gramsci, 80, 20054 Segrate MI, Italia

Unverified

See Details

Pap Smear by Synlab

Piazza Centro Commerciale, 4, 20054 Segrate MI, Italia

Unverified

See Details

Pap Test by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€65.00

€61.75 with our promocode

See Details

test HPV cavo orale autoprelievo by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€65.00

€61.75 with our promocode

See Details

Pap Smear by Synlab

Via Antonio Gramsci, 62, 20055 Vimodrone MI, Italia

1.6 km

Unverified

See Details

Pap Smear by Synlab

Piazza Italia, 3, 20093 Cologno Monzese MI, Italia

2.8 km

Unverified

See Details

Pap Smear by Synlab

Via Giuseppe Verdi, 36, 20063 Cernusco sul Naviglio MI, Italia

3.1 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Viale Monza, 43 20127 Milano (MI)

5.2 km

Unverified

See Details

Pap Smear by Centro Medico Meditel Saronno

Viale Monza, 2, 20127 Milano MI, Italia

5.2 km

Unverified

See Details

Pap Smear by Synlab

Piazza Europa, 9, 20051 Cassina de' Pecchi MI, Italia

4 km

Unverified

See Details

Pap Smear by Synlab

Via Romualdo Bonfadini, 84, 20138 Milano MI, Italia

5.2 km

Unverified

See Details

Pap Smear by Synlab

Via Cesare Battisti, 38, 20093 Cologno Monzese MI, Italia

2.8 km

Unverified

See Details

Pap Smear by Synlab

Via Gaetano Salvemini, 28, 20099 Sesto San Giovanni MI, Italia

4 km

Unverified

See Details

Pap Smear by Synlab

Viale Ercole Marelli, 19, 20099 Sesto San Giovanni MI, Italia

4 km

Unverified

See Details

Anogenital cancers - symptoms and how to test

Human papillomavirus (HPV) infection is linked to anogenital malignancies, namely to the alpha genus of mucosal HPV types 16 and 1810,11. There is some evidence that beta-genus HPVs contribute to cutaneous SCC, although it is inconclusive. High-risk HPVs account for 3% of all female malignancies and 2% of all male cancers in the United States. The Centers for Disease Control and Prevention report that each year there are around 45,000 new instances of cancer in areas of the body where HPV is often present. HPV is predicted to cause approximately 36,000 of these (CDC). The HPV test screens for the presence of high-risk HPV strains that are associated with an increased risk of developing cervix precancers and malignancies.